These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2250573)

  • 21. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
    Jenner P; Rupniak NM; Rose S; Kelly E; Kilpatrick G; Lees A; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):85-90. PubMed ID: 6436758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamatergic compensatory mechanisms in experimental parkinsonism.
    Bezard E; Bioulac B; Gross CE
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):609-23. PubMed ID: 9682276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model].
    Takeda M
    Hokkaido Igaku Zasshi; 1995 Nov; 70(6):829-38. PubMed ID: 8582706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.
    Bergman H; Wichmann T; Karmon B; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):507-20. PubMed ID: 7983515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism.
    Filion M; Tremblay L; Bédard PJ
    Brain Res; 1991 Apr; 547(1):152-61. PubMed ID: 1677608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of thalamotomy in the treatment of levodopa-induced dyskinesia.
    Page RD
    Acta Neurochir (Wien); 1992; 114(3-4):77-117. PubMed ID: 1580197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of experimental parkinsonism by using selective chemical ablation of the medial globus pallidus.
    Lieberman DM; Corthesy ME; Cummins A; Oldfield EH
    J Neurosurg; 1999 May; 90(5):928-34. PubMed ID: 10223460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP. A study of behavior, biochemistry and histology.
    Chen SD; Zhou XD; Xu DL; Li GW; Tang QM; Xu XR
    Chin Med J (Engl); 1991 Sep; 104(9):758-63. PubMed ID: 1935358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
    Kaneda K; Tachibana Y; Imanishi M; Kita H; Shigemoto R; Nambu A; Takada M
    Eur J Neurosci; 2005 Dec; 22(12):3241-54. PubMed ID: 16367790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease.
    Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM
    Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
    Kuno S; Mizuta E; Nishida J; Takechi M
    Clin Neuropharmacol; 1992 Oct; 15(5):381-6. PubMed ID: 1384970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lesions in monkey globus pallidus externus exacerbate parkinsonian symptoms.
    Zhang J; Russo GS; Mewes K; Rye DB; Vitek JL
    Exp Neurol; 2006 Jun; 199(2):446-53. PubMed ID: 16487515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
    Nomoto M; Jenner P; Marsden CD
    Neurosci Lett; 1985 Jun; 57(1):37-41. PubMed ID: 3162113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys.
    Klockgether T; Turski L; Honoré T; Zhang ZM; Gash DM; Kurlan R; Greenamyre JT
    Ann Neurol; 1991 Nov; 30(5):717-23. PubMed ID: 1662477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational physiology of the basal ganglia in Parkinson's disease.
    Rivlin-Etzion M; Elias S; Heimer G; Bergman H
    Prog Brain Res; 2010; 183():259-73. PubMed ID: 20696324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for non-NMDA excitatory amino acid receptors in regulating the basal activity of rat globus pallidus neurons and their activation by the subthalamic nucleus.
    Soltis RP; Anderson LA; Walters JR; Kelland MD
    Brain Res; 1994 Dec; 666(1):21-30. PubMed ID: 7534195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ethosuximide on rest tremor in the MPTP monkey model.
    Gomez-Mancilla B; Latulippe JF; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(2):137-41. PubMed ID: 1350061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.